Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.

Clinical Trial Description

The objective of this study is to determine whether SONDA is non-inferior in predicting visual field limitations compared to the SAP in patients with a (supra)sellar tumor. The study population will be made up of patients with a (supra)sellar tumor complicated by compression of the optic chiasm as well as healthy controls. The patients will be asked to join the study when the patients are referred to the UMCG for further diagnostics and treatment. In case the patients show signs of visual field loss the patients will be asked to participate in the study. The researchers will reuse data from healthy controls collected in previous studies where possible and, if necessary for age matching, recruit new participants. Participants will be asked to perform the SONDA test before and after surgery. The first time the participants will perform the test twice and will also perform routine eye test and be asked to fill in a questionnaire to evaluate the experience. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06266949
Study type	Observational
Source	University Medical Center Groningen
Contact	Jos MA Kuijlen, MD/PHD
Phone	050 361 2837
Email	jmakuijlen@umcg.nl
Status	Not yet recruiting
Phase
Start date	April 1, 2024
Completion date	April 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04529356` - The TMS Treatment for Postoperative Headache in GH Tumor	N/A
Completed	`NCT03363126` - Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma	N/A
Completed	`NCT04212793` - Detection of PitNET Tissue During TSS Using Bevacizumab-800CW	Phase 1
Recruiting	`NCT03309319` - A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas	N/A
Terminated	`NCT04106531` - Validation of a Quality of Life Metric "Prolac-10"
Recruiting	`NCT03719781` - Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery
Recruiting	`NCT01556230` - Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Recruiting	`NCT03132259` - Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach	Phase 4
Recruiting	`NCT01368133` - The Observational Study of Growth Hormone-secreting Pituitary Tumors	N/A
Withdrawn	`NCT04863339` - Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery	Phase 2
Terminated	`NCT00646308` - Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas	N/A
Recruiting	`NCT00852501` - Characterization of Receptors in Non-functioning Pituitary Macroadenomas	Phase 4
Completed	`NCT03465423` - Comparison of Propofol Requirement Between Patients With Pituitary Somatotroph Tumor and With Nonfunctioning Pituitary Tumor in Transsphenoidal Pituitary Surgery Under Total Intravenous Anesthesia
Recruiting	`NCT03474601` - Seoul National University Pituitary Disease Cohort Study
Recruiting	`NCT05139277` - Evaluation of the CONVIVO System	N/A
Active, not recruiting	`NCT03636568` - Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)	N/A
Completed	`NCT02813044` - Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor	N/A
Recruiting	`NCT03973450` - Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
Active, not recruiting	`NCT04042753` - Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors	Phase 2
Recruiting	`NCT04018963` - The Impact of Endoscopic Pituitary Surgery on Nasal Function